-- RBT-101, Radiant's lead oncology program and 4-1BB agonist, demonstrated robust, durable and complete tumor regression without liver toxicity in MC38 colorectal mouse tumor model -- Poster ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback